Definium Therapeutics issues inducement stock options for 32,900 shares to new hires
DFTX•Inducement stock options granted to two new employees
Definium Therapeutics issued inducement stock options covering 32,900 common shares to two newly hired non-executive employees.
The grants have an effective date of Aug. 17, 2026, with an exercise price set at the closing share price on that day.
Vesting runs over four years: 25% after year one, with the remaining 75% vesting monthly over the following three years.
